News
-
-
PRESS RELEASE
Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG to Buy with a target price of EUR 1.10. Analysis includes H1 2025 results and future outlook -
-
PRESS RELEASE
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position
NanoViricides, Inc. files Form 10-Q for Q3 2025 with SEC, presents NV-387 as broad-spectrum antiviral drug addressing unmet medical needs. Company strengthens financial position with recent financings -
-
-
-
PRESS RELEASE
DeFi Technologies Announces Leadership Transition: Olivier Roussy Newton Resigns as CEO and Chairman; Co-Founder Johan Wattenström Appointed as Successor
DeFi Technologies announces leadership transition as Olivier Roussy Newton resigns as CEO and Chairman; Johan Wattenström appointed as successor. Company's growth and milestones under Roussy Newton's leadership highlighted -
PRESS RELEASE
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Jaguar Health, Inc. reports proof-of-concept trial shows crofelemer potential for MVID patients, financial results revealed, FDA meeting outcome, and upcoming investor webcast -